Sleep apnea, which involves recurring, temporary interruptions of breathing during sleep, can disturb regulation of blood lipid levels, a key factor in the development of cardiovascular disease.
A genome-wide study of 402,398 individuals identifies 369 SNPs associated with insulin resistance, offering insights into metabolic diseases and potential therapeutic targets.